Literature DB >> 23463135

Microgavage of zebrafish larvae.

Jordan L Cocchiaro1, John F Rawls.   

Abstract

The zebrafish has emerged as a powerful model organism for studying intestinal development(1-5), physiology(6-11), disease(12-16), and host-microbe interactions(17-25). Experimental approaches for studying intestinal biology often require the in vivo introduction of selected materials into the lumen of the intestine. In the larval zebrafish model, this is typically accomplished by immersing fish in a solution of the selected material, or by injection through the abdominal wall. Using the immersion method, it is difficult to accurately monitor or control the route or timing of material delivery to the intestine. For this reason, immersion exposure can cause unintended toxicity and other effects on extraintestinal tissues, limiting the potential range of material amounts that can be delivered into the intestine. Also, the amount of material ingested during immersion exposure can vary significantly between individual larvae(26). Although these problems are not encountered during direct injection through the abdominal wall, proper injection is difficult and causes tissue damage which could influence experimental results. We introduce a method for microgavage of zebrafish larvae. The goal of this method is to provide a safe, effective, and consistent way to deliver material directly to the lumen of the anterior intestine in larval zebrafish with controlled timing. Microgavage utilizes standard embryo microinjection and stereomicroscopy equipment common to most laboratories that perform zebrafish research. Once fish are properly positioned in methylcellulose, gavage can be performed quickly at a rate of approximately 7-10 fish/ min, and post-gavage survival approaches 100% depending on the gavaged material. We also show that microgavage can permit loading of the intestinal lumen with high concentrations of materials that are lethal to fish when exposed by immersion. To demonstrate the utility of this method, we present a fluorescent dextran microgavage assay that can be used to quantify transit from the intestinal lumen to extraintestinal spaces. This test can be used to verify proper execution of the microgavage procedure, and also provides a novel zebrafish assay to examine intestinal epithelial barrier integrity under different experimental conditions (e.g. genetic manipulation, drug treatment, or exposure to environmental factors). Furthermore, we show how gavage can be used to evaluate intestinal motility by gavaging fluorescent microspheres and monitoring their subsequent transit. Microgavage can be applied to deliver diverse materials such as live microorganisms, secreted microbial factors/toxins, pharmacological agents, and physiological probes. With these capabilities, the larval zebrafish microgavage method has the potential to enhance a broad range of research fields using the zebrafish model system.

Entities:  

Mesh:

Year:  2013        PMID: 23463135      PMCID: PMC3605733          DOI: 10.3791/4434

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  42 in total

1.  Quantitative analysis of peristalsis in the guinea-pig small intestine using spatio-temporal maps.

Authors:  G W Hennig; M Costa; B N Chen; S J Brookes
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

2.  Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers.

Authors:  C J Watson; M Rowland; G Warhurst
Journal:  Am J Physiol Cell Physiol       Date:  2001-08       Impact factor: 4.249

3.  Intestinal growth and differentiation in zebrafish.

Authors:  Kenneth N Wallace; Shafinaz Akhter; Erin M Smith; Kristin Lorent; Michael Pack
Journal:  Mech Dev       Date:  2005-02       Impact factor: 1.882

4.  Formation of the digestive system in zebrafish: III. Intestinal epithelium morphogenesis.

Authors:  Annie N Y Ng; Tanya A de Jong-Curtain; David J Mawdsley; Sara J White; Jimann Shin; Bruce Appel; P Duc Si Dong; Didier Y R Stainier; Joan K Heath
Journal:  Dev Biol       Date:  2005-10-01       Impact factor: 3.582

5.  Ca2+ regulation of tight-junction permeability and structure in Necturus gallbladder.

Authors:  C E Palant; M E Duffey; B K Mookerjee; S Ho; C J Bentzel
Journal:  Am J Physiol       Date:  1983-09

6.  Tight junction formation in cultured epithelial cells (MDCK).

Authors:  L Gonzalez-Mariscal; B Chávez de Ramírez; M Cereijido
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

7.  Ontogeny of the gut motility control system in zebrafish Danio rerio embryos and larvae.

Authors:  Anna Holmberg; Thorsten Schwerte; Bernd Pelster; Susanne Holmgren
Journal:  J Exp Biol       Date:  2004-11       Impact factor: 3.312

8.  Unique and conserved aspects of gut development in zebrafish.

Authors:  Kenneth N Wallace; Michael Pack
Journal:  Dev Biol       Date:  2003-03-01       Impact factor: 3.582

9.  Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota.

Authors:  John F Rawls; Buck S Samuel; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

10.  Mutations affecting development of zebrafish digestive organs.

Authors:  M Pack; L Solnica-Krezel; J Malicki; S C Neuhauss; A F Schier; D L Stemple; W Driever; M C Fishman
Journal:  Development       Date:  1996-12       Impact factor: 6.868

View more
  34 in total

1.  Loss-of-Function Mutations in UNC45A Cause a Syndrome Associating Cholestasis, Diarrhea, Impaired Hearing, and Bone Fragility.

Authors:  Clothilde Esteve; Ludmila Francescatto; Perciliz L Tan; Aurélie Bourchany; Cécile De Leusse; Evelyne Marinier; Arnaud Blanchard; Patrice Bourgeois; Céline Brochier-Armanet; Ange-Line Bruel; Arnauld Delarue; Yannis Duffourd; Emmanuelle Ecochard-Dugelay; Géraldine Hery; Frédéric Huet; Philippe Gauchez; Emmanuel Gonzales; Catherine Guettier-Bouttier; Mina Komuta; Caroline Lacoste; Raphaelle Maudinas; Karin Mazodier; Yves Rimet; Jean-Baptiste Rivière; Bertrand Roquelaure; Sabine Sigaudy; Xavier Stephenne; Christel Thauvin-Robinet; Julien Thevenon; Jacques Sarles; Nicolas Levy; Catherine Badens; Olivier Goulet; Jean-Pierre Hugot; Nicholas Katsanis; Laurence Faivre; Alexandre Fabre
Journal:  Am J Hum Genet       Date:  2018-02-08       Impact factor: 11.025

Review 2.  Zebrafish as a model for zoonotic aquatic pathogens.

Authors:  Hannah M Rowe; Jeffrey H Withey; Melody N Neely
Journal:  Dev Comp Immunol       Date:  2014-03-06       Impact factor: 3.636

3.  Lysosome-Rich Enterocytes Mediate Protein Absorption in the Vertebrate Gut.

Authors:  Jieun Park; Daniel S Levic; Kaelyn D Sumigray; Jennifer Bagwell; Oznur Eroglu; Carina L Block; Cagla Eroglu; Robert Barry; Colin R Lickwar; John F Rawls; Stephen A Watts; Terry Lechler; Michel Bagnat
Journal:  Dev Cell       Date:  2019-08-29       Impact factor: 12.270

Review 4.  The zebrafish as a model for gastrointestinal tract-microbe interactions.

Authors:  Erika M Flores; Anh T Nguyen; Max A Odem; George T Eisenhoffer; Anne Marie Krachler
Journal:  Cell Microbiol       Date:  2020-01-07       Impact factor: 3.715

5.  Organ-targeted high-throughput in vivo biologics screen identifies materials for RNA delivery.

Authors:  Tsung-Yao Chang; Peng Shi; Joseph D Steinmeyer; Itthi Chatnuntawech; Paul Tillberg; Kevin T Love; Peter M Eimon; Daniel G Anderson; Mehmet Fatih Yanik
Journal:  Integr Biol (Camb)       Date:  2014-09-03       Impact factor: 2.192

6.  Epigenetic control of intestinal barrier function and inflammation in zebrafish.

Authors:  Lindsay Marjoram; Ashley Alvers; M Elizabeth Deerhake; Jennifer Bagwell; Jamie Mankiewicz; Jordan L Cocchiaro; Rebecca W Beerman; Jason Willer; Kaelyn D Sumigray; Nicholas Katsanis; David M Tobin; John F Rawls; Mary G Goll; Michel Bagnat
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

7.  Developmental regulation of apical endocytosis controls epithelial patterning in vertebrate tubular organs.

Authors:  Alejo E Rodríguez-Fraticelli; Jennifer Bagwell; Minerva Bosch-Fortea; Gaelle Boncompain; Natalia Reglero-Real; Maria J García-León; Germán Andrés; Maria L Toribio; Miguel A Alonso; Jaime Millán; Franck Perez; Michel Bagnat; Fernando Martín-Belmonte
Journal:  Nat Cell Biol       Date:  2015-02-23       Impact factor: 28.824

8.  Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction.

Authors:  Elena Bonora; Francesca Bianco; Lina Cordeddu; Michael Bamshad; Ludmila Francescatto; Dustin Dowless; Vincenzo Stanghellini; Rosanna F Cogliandro; Greger Lindberg; Zeynel Mungan; Kivanc Cefle; Tayfun Ozcelik; Sukru Palanduz; Sukru Ozturk; Asuman Gedikbasi; Alessandra Gori; Tommaso Pippucci; Claudio Graziano; Umberto Volta; Giacomo Caio; Giovanni Barbara; Mauro D'Amato; Marco Seri; Nicholas Katsanis; Giovanni Romeo; Roberto De Giorgio
Journal:  Gastroenterology       Date:  2015-01-06       Impact factor: 22.682

9.  Enteroendocrine cells sense bacterial tryptophan catabolites to activate enteric and vagal neuronal pathways.

Authors:  Lihua Ye; Munhyung Bae; Chelsi D Cassilly; Sairam V Jabba; Daniel W Thorpe; Alyce M Martin; Hsiu-Yi Lu; Jinhu Wang; John D Thompson; Colin R Lickwar; Kenneth D Poss; Damien J Keating; Sven-Eric Jordt; Jon Clardy; Rodger A Liddle; John F Rawls
Journal:  Cell Host Microbe       Date:  2020-12-21       Impact factor: 21.023

10.  Disruptive CHD8 mutations define a subtype of autism early in development.

Authors:  Raphael Bernier; Christelle Golzio; Bo Xiong; Holly A Stessman; Bradley P Coe; Osnat Penn; Kali Witherspoon; Jennifer Gerdts; Carl Baker; Anneke T Vulto-van Silfhout; Janneke H Schuurs-Hoeijmakers; Marco Fichera; Paolo Bosco; Serafino Buono; Antonino Alberti; Pinella Failla; Hilde Peeters; Jean Steyaert; Lisenka E L M Vissers; Ludmila Francescatto; Heather C Mefford; Jill A Rosenfeld; Trygve Bakken; Brian J O'Roak; Matthew Pawlus; Randall Moon; Jay Shendure; David G Amaral; Ed Lein; Julia Rankin; Corrado Romano; Bert B A de Vries; Nicholas Katsanis; Evan E Eichler
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.